tRF-29-79通过调解谷氨酸运输体SLC1A5A5调节肺腺癌的进展
Yuanjian Shi1,2,3, Zehao Pan1,2,3, Yipeng Feng1,2,3
1Department of Thoracic Surgery, Affiliated Cancer Hospital of Nanjing Medical University, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, 42 Baiziting Road, Xuanwu District, Nanjing 210009, China.
一个新的tRNA衍生片段 (tRF),tRF-29-79,在肺腺癌 (LUAD) 中被降低调节. 这种tRF通过通过PTBP1和SLC1A5mRNA剪接调节谷氨胺代谢来抑制LUAD进展.
科学领域:
- * 分子生物学 * 分子生物学
- * 瘤学 在线咨询
- *RNA生物学 *RNA生物学
背景情况:
- *tRNA衍生碎片 (tRFs) 与癌症进展有关.
- * tRFs在肺腺癌 (LUAD) 中的特定作用尚不清楚.
研究的目的:
- * 为了研究tRF-29-79在LUAD中的功能和机制.
- * 确定用于LUAD治疗的新型治疗点.
主要方法:
- * 在LUAD组织中分析tRF表达.
- *体内和体外测试,以评估tRF-29-79对LUAD细胞的影响.
- * 涉及RNA结合蛋白PTBP1和SLC1A5mRNA的机制研究.
主要成果:
- *tRF-29-79在LUAD下调,并与更差的预后有关.
- *tRF-29-79抑制了LUAD细胞的增殖,迁移和入侵.
- *tRF-29-79通过通过PTBP1相互作用和替代拼接影响SLC1A5mRNA稳定性来调节谷氨胺代谢.
结论:
- *tRF-29-79在LUAD中表现出瘤抑制功能.
- *tRF-29-79代表了LUAD的潜在生物标志物和治疗标.
- * 这项研究揭示了在LUAD中通过tRF调节谷氨胺代谢的新奇机制.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
09:38Establishment and Characterization of Three Afatinib-resistant Lung Adenocarcinoma PC-9 Cell Lines Developed with Increasing Doses of Afatinib
Published on: June 26, 2019
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
